Innovotech Inc (IOT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Innovotech Inc (IOT) has a cash flow conversion efficiency ratio of 0.039x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$140.68K ≈ $101.76K USD) by net assets (CA$3.65 Million ≈ $2.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Innovotech Inc - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Innovotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Innovotech Inc for a breakdown of total debt and financial obligations.
Innovotech Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Innovotech Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Soco Corporation Ltd
AU:SOC
|
-0.288x |
|
Noroo Holdings Co Ltd
KO:000325
|
0.010x |
|
Nexgel Inc
NASDAQ:NXGL
|
0.057x |
|
Trio Petroleum Corp.
NYSE MKT:TPET
|
-0.060x |
|
KST Beteiligungs AG
F:KSW
|
N/A |
|
Enlitic Inc
AU:ENL
|
-0.698x |
|
Nutritional Growth Solutions Ltd
AU:NGS
|
-2.363x |
|
Archidply Decor Limited
NSE:ADL
|
0.012x |
Annual Cash Flow Conversion Efficiency for Innovotech Inc (2003–2025)
The table below shows the annual cash flow conversion efficiency of Innovotech Inc from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see Innovotech Inc (IOT) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$3.65 Million ≈ $2.64 Million |
CA$-62.35K ≈ $-45.11K |
-0.017x | +45.09% |
| 2024-12-31 | CA$2.62 Million ≈ $1.90 Million |
CA$-81.64K ≈ $-59.06K |
-0.031x | +86.37% |
| 2023-12-31 | CA$998.60K ≈ $722.37K |
CA$-228.08K ≈ $-164.99K |
-0.228x | -215.91% |
| 2022-12-31 | CA$1.06 Million ≈ $764.99K |
CA$208.39K ≈ $150.75K |
0.197x | +826.07% |
| 2021-12-31 | CA$1.18 Million ≈ $851.37K |
CA$25.04K ≈ $18.12K |
0.021x | -92.17% |
| 2020-12-31 | CA$644.98K ≈ $466.57K |
CA$175.24K ≈ $126.76K |
0.272x | -65.07% |
| 2019-12-31 | CA$98.09K ≈ $70.95K |
CA$76.30K ≈ $55.19K |
0.778x | +125.90% |
| 2018-12-31 | CA$93.47K ≈ $67.61K |
CA$-280.75K ≈ $-203.09K |
-3.004x | -243.54% |
| 2017-12-31 | CA$181.51K ≈ $131.30K |
CA$-158.69K ≈ $-114.80K |
-0.874x | -45878.85% |
| 2016-12-31 | CA$-1.22 Million ≈ $-881.43K |
CA$2.32K ≈ $1.68K |
-0.002x | +95.34% |
| 2015-12-31 | CA$-1.00 Million ≈ $-725.51K |
CA$40.90K ≈ $29.58K |
-0.041x | -135.58% |
| 2014-12-31 | CA$-765.66K ≈ $-553.87K |
CA$-87.75K ≈ $-63.48K |
0.115x | -88.37% |
| 2013-12-31 | CA$-569.33K ≈ $-411.85K |
CA$-560.96K ≈ $-405.79K |
0.985x | +6432.59% |
| 2003-12-31 | CA$836.94K ≈ $605.43K |
CA$-13.02K ≈ $-9.42K |
-0.016x | -171.08% |
| 2003-09-30 | CA$841.40K ≈ $608.65K |
CA$18.42K ≈ $13.32K |
0.022x | -- |
About Innovotech Inc
Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assa… Read more